|
|
| OMB APPROVAL |
|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 | OMB Number: 3235-0167 Expires: August 31, 2027 Estimated average burden hours per response................. 1.50 |
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER
SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION
OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934.
Commission File Number 000-55299
| Nascent Biotech Inc. |
| (Exact name of registrant as specified in its charter) |
NASCENT BIOTECH INC 631 US Hwy 1 Suite 407, North Palm Beach, FL 33408
(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)
Common Stock
(Title of each class of securities covered by this Form)
___________________________________________________________________________________________
(Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains)
Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:
|
| Rule 12g-4(a)(1) | ☒ |
|
| Rule 12g-4(a)(2) | ☐ |
|
| Rule 12h-3(b)(1)(I) | ☐ |
|
| Rule 12h-3(b)(1)(ii) | ☐ |
|
| Rule 15d-6 | ☐ |
|
| Rule 15d-22(b) | ☐ |
Approximate number of holders of record as of the certification or notice date: 163
Pursuant to the requirements of the Securities Exchange Act of 1934 (Nascent Biotech Inc has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.
| Date: March 31, 2025 | By: /s/ Lowell Holden |
|
| Title: CFO |
| SEC 2069 (08-11) | Potential persons who are to respond to the collection of information contained in this Form are not required to respond unless the Form displays a currently valid OMB control number. |
| Board of Governors of the Federal Reserve System | OMB Number 7100-0091 | Approval expires February 28, 2026 |
Instruction: This form is required by Rules 12g-4, 12h-3, 15d-6 and 15d-22 of the General Rules and Regulations under the Securities Exchange Act of 1934. The registrant shall file with the Commission three copies of Form 15, one of which shall be manually signed. It may be signed by an officer of the registrant, by counsel or by any other duly authorized person. The name and title of the person signing the form shall be typed or printed under the signature.
| 2 of 2 |